These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3963978

  • 41. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS, Choi EK, Heo NY, Hong SC, Myung SJ, Yang SK, Kim JH, Song JK, Yoo B, Yu CS.
    Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
    [Abstract] [Full Text] [Related]

  • 42. [The diagnostic significance of neutrophil adhesive reactions in rheumatoid arthritis].
    Fomina LL, Rakhmatullina AI.
    Ter Arkh; 1993 May; 65(6):72-6, 79. PubMed ID: 8378855
    [Abstract] [Full Text] [Related]

  • 43. Behçet's syndrome.
    Yazici H, Yurdakul S, Hamuryudan V.
    Curr Opin Rheumatol; 1999 Jan; 11(1):53-7. PubMed ID: 9894631
    [Abstract] [Full Text] [Related]

  • 44. Systemic vasculitis and the gut.
    Hatemi I, Hatemi G, Çelik AF.
    Curr Opin Rheumatol; 2017 Jan; 29(1):33-38. PubMed ID: 27684357
    [Abstract] [Full Text] [Related]

  • 45. Bowel-associated dermatosis-arthritis syndrome. Immune complex-mediated vessel damage and increased neutrophil migration.
    Jorizzo JL, Schmalstieg FC, Dinehart SM, Daniels JC, Cavallo T, Apisarnthanarax P, Rudloff HB, Gonzalez EB.
    Arch Intern Med; 1984 Apr; 144(4):738-40. PubMed ID: 6712372
    [Abstract] [Full Text] [Related]

  • 46. Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behçet's disease-like animal model.
    Sohn S, Lee ES, Lee SI, Kim YA, Kwon HJ, Bang D, Lee S.
    Adv Exp Med Biol; 2003 Apr; 528():585-9. PubMed ID: 12918770
    [No Abstract] [Full Text] [Related]

  • 47. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide.
    Eisenbud L, Horowitz I, Kay B.
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):289-92. PubMed ID: 3477744
    [Abstract] [Full Text] [Related]

  • 48. [An analysis of adverse drug reactions of thalidomide in treatment of immune-related bowel diseases].
    Luo HQ, Tan B, Lü H, Qian JM.
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):726-9. PubMed ID: 24314159
    [Abstract] [Full Text] [Related]

  • 49. Behçet's syndrome. The Cerrahpasa experience. Members of the Behçet's Syndrome Research Centre.
    Yazici H, Fresko I, Hamuryudan V, Mat C, Melikoglu M, Ozyazgan Y, Tuzun Y, Yurdakul S.
    Adv Exp Med Biol; 1999 Sep; 455():135-40. PubMed ID: 10599334
    [Abstract] [Full Text] [Related]

  • 50. Thalidomide in the treatment of neuro-Behçet's syndrome.
    Ranselaar CG, Boone RM, Kluin-Nelemans HC.
    Br J Dermatol; 1986 Sep; 115(3):367-70. PubMed ID: 3756093
    [Abstract] [Full Text] [Related]

  • 51. Behçet's disease--a rheumatologic perspective.
    Lee SK, Lee J.
    Yonsei Med J; 1997 Dec; 38(6):395-400. PubMed ID: 9509909
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Thalidomide: focus on its employment in rheumatologic diseases.
    Ossandon A, Cassarà EA, Priori R, Valesini G.
    Clin Exp Rheumatol; 2002 Dec; 20(5):709-18. PubMed ID: 12412207
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Thalidomide and cell mediated immunity in Behçet's disease.
    Hamza M, Hamzaoui K, Ayed K, Eleuch M, Zribi A.
    Clin Rheumatol; 1987 Dec; 6(4):608-9. PubMed ID: 3449313
    [No Abstract] [Full Text] [Related]

  • 57. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
    Gardner-Medwin JM, Smith NJ, Powell RJ.
    Ann Rheum Dis; 1994 Dec; 53(12):828-32. PubMed ID: 7864692
    [Abstract] [Full Text] [Related]

  • 58. Sucessful use of thalidomide in severe gastrointestinal Behçet's disease.
    Lim YK, Keating JP, Steele R.
    ANZ J Surg; 2015 Jun; 85(6):496. PubMed ID: 26031928
    [No Abstract] [Full Text] [Related]

  • 59. Treatment of severe colitis in Behçet's syndrome with thalidomide (CG-217).
    Larsson H.
    J Intern Med; 1990 Oct; 228(4):405-7. PubMed ID: 2266351
    [Abstract] [Full Text] [Related]

  • 60. Thalidomide in gastrointestinal disorders.
    Bousvaros A, Mueller B.
    Drugs; 2001 Oct; 61(6):777-87. PubMed ID: 11398909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.